glp-1 drugs companies Insurance scrambling to support need for - Insurance News glp-1 drugs pharmaceutical companies partnerships
Description
Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy.
95% CI: 0.8, 0.9
This is a huge market
Here is how they compare
What Is A GLP-1 Agonist
Similar to other diabetes drugs, metformin and Ozempic are used for managing blood sugar levels
